Myconostica labs launched
April 2007Spin out biotechnology company Myconostica has launched its new laboratory complex, in an opening ceremony presided over by President and Vice Chancellor Professor Alan Gilbert. Professor Gilbert officially opened the complex in Sharston, which allows the company to house its development and production in one location.
Myconostica specialises in molecular diagnostic tests for life-threatening respiratory fungal infection, and having secured venture capital funding from Amphion PLC is set to launch its first product this year. The company was founded by Professor of Medicine and Medical Mycology David Denning, with assistance from The University of Manchester Intellectual Property Limited (UMIP).
Professor Gilbert praised the remarkable teamwork between Professor Denning, UMIP and the local business community in attracting venture capital, and related it to the University’s 2015 agenda. “Myconostica perfectly illustrates how the University can contribute to the local and national economy, in this case providing new diagnostic products to improve health worldwide,” he said.
UMIP CEO Clive Rowland, added: “The growth of Myconostica as a business in such a short space of time, coupled with its success in attracting venture capital funds, shows how successful the University model for IP commercialisation can be. It is crucial that we continue to work positively with academics and entrepreneurs to help commercialise research; the contribution these ventures make will have a lasting, beneficial effect on the North West and international economies.”
The University of Manchester is not responsible for the content of external internet sites.
